BASF

Last updated January 31, 2026

319

Innovation Areas

13,244

Inventors

154

Collaborations

Botanical extract and microrna inhibitors: BASFRecent Research Landscape

Raw botanical extracts suffer from poor bioavailability and inconsistent efficacy in topical applications. Controlled enzymatic hydrolysis of specific seed and fruit proteins creates standardized peptides that stabilize skin barrier function.

What technical problems is BASF addressing in Botanical extract and microrna inhibitors?

Biological tissue degradation

(14)evidences

External pollutants and oxidative stress cause structural protein breakdown in dermal tissues. Preventing this degradation maintains skin barrier integrity and aesthetic elasticity.

Skin microbiota dysbiosis

(8)evidences

Imbalances in the cutaneous microbial ecosystem lead to inflammatory conditions and barrier dysfunction. Restoring microbial equilibrium prevents dermatological pathologies and premature tissue aging.